secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viridian Therapeutics, Inc.\DE (VRDN)
CIK:        0001590750
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0001193125-23-269415
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Scott Myers resigns from Viridian board; company adopts amended bylaws effective Nov 1, 2023
--------------------------------------------------------------------------------

- Scott Myers resigned from the board effective Oct 29, 2023; departure not due to any disagreement with the company.
- Board adopted Third Amended and Restated Bylaws effective Nov 1, 2023.
- Bylaws modify notice period required to call a special meeting of the Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590750/000119312523269415/0001193125-23-269415-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590750/000119312523269415/d557083d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-269415

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer